Your browser doesn't support javascript.
loading
Clinical Research of Huanglian Jiedu Decoction for Intervention of Dyslipidemia / 广州中医药大学学报
Article in Zh | WPRIM | ID: wpr-603234
Responsible library: WPRO
ABSTRACT
Objective To observe the effect of Huanglian Jiedu Decoction ( HJD) for the treatment of dyslipidemia, thus to provide evidence for the prevention and treatment of dyslipidemia with traditional Chinese medicine. Methods A total of 80 dyslipidemia patients were randomized into HJD group ( 50 cases) and simvastatin group ( 30 cases) . After treatment for 4 weeks, blood lipid levels, metabolic parameters and alanine aminotransferase (ALT) levels were detected. Results (1) After treatment, HJD group and simvastatin group both had lower total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol levels (P0.05). ( 2) After treatment, uric acid was reduced in HJD group ( P0.05). The inter-group comparison showed that HJD had lower blood glucose level than simvastatin group, and the difference had statisticall significance ( P<0.05). ( 3) During the treatment, the patients showed good compliance, and had no obvious hepatic or renal damage. Conclusion HJD could reduce TC, TG and low density lipoprotein cholesterol, and increase high density lipoprotein cholesterol of dyslipidemia patients, the effect being similar to simvastatin. HJD could also significantly reduce uric acid of dyslipidemia patients, showing good safety.
Key words
Full text: 1 Index: WPRIM Type of study: Clinical_trials Language: Zh Journal: Journal of Guangzhou University of Traditional Chinese Medicine Year: 2015 Type: Article
Full text: 1 Index: WPRIM Type of study: Clinical_trials Language: Zh Journal: Journal of Guangzhou University of Traditional Chinese Medicine Year: 2015 Type: Article